to them,7~10) we shall only show here their structures in order to indicate the diversity of the aminocyclitol antibiotics. We specifically limit our list to those antibiotics containing at least one aminocyclohexanol (aminocyclitol) ring.
The presently known aminocyclitol antibiotics can be divided into a number of distinct groups according to the aminocyclitol present. The largest is that containing deoxystreptamine and this group can be further divided into those antibiotics in which deoxystreptamine is substituted on two adjacent hydroxyls (4,5-disubstituted deoxystreptamine group), those in which deoxystreptamine is substituted on two non-adjacent hydroxyls (4,6-disubstituted deoxystreptamines), and those in which deoxystreptamine is monosubstituted. The 4,5-disubstituted deoxystreptamine antibiotics are shown in Fig. 1 . These include the neomycins,2) the paromomycins,2) the lividomycins,20) ribostamycin,7) xylostasin,21) and the butirosins22) (including BU-1709E1 and E223) and LL BM-408a24). The 4,6-disubstituted deoxystreptamine antibiotics (Fig. 2) include the kanamycins,1~4,12) tobramycin and its relatives the nebramycins,8) the seldomycins,25) and the gentamicins5,6,26~30) and related compounds such as JI-20A and B,31a) G-4183 1b) sisomicin,32) verdamicin,33) 66-40B and D,34) and G-52.35) Antibiotics which are monosubstituted on deoxystrep- This group includes validamycins A and E,11) with two aminocyclitol rings which bear both C-alkyl and N-alkyl substituents, hygromycin A, 41) and minosaminomycin42) (Fig. 5) . The deoxystreptamine-containing antibiotics constitute the largest group of aminocyclitol antibiotics and we shall discuss their biosynthesis first. The bulk of the effort in this class has been directed toward neomycin, whose biosynthesis was last surveyed in 1967.43) The structure of neomycin B is shown in Fig. 6 , with the four subunits identified. In addition to deoxystreptamine, there are two diaminohexoses, 2,6-diamino-2,6-dideoxy-D-glucose (neosamine C) and 2,6-diamino-2,6-dideoxy-L-idose (neosamine B), Plus D-ribose. Studies prior to 196744,45) demonstrated that both [1-14C]glucose and [6-14C]glucose (Table 1) are well incorporated into neomycin and that all subunits of the antibiotic are labeled approximately equally, except ribose, which is labeled to a somewhat lesser extent. A current version of the degradation scheme giving the subunits is shown in Fig. 7 . A milder hydrolysis of diacetylneobiosamine B allows isolation of ribose.
The specificity of labeling of the subunits by 14C-labeled glucose has also been investigated, 44, 45) following the periodate degradation schemes shown in Fig. 8 . D-Glucose labels the neosamines in the corresponding positions ( Fig. 9 ), i.e., C-1 of glucose labels C-1 of the neosamines, C-6 of glucose labels C-6 of the neosamines.46) A reasonable pathway for conversion of glucose to neosamines B and C, involving glucosamine as an intermediate (see below), is shown in Fig. 10 . The labeling pattern in ribose is more interesting and implies that two pathways must be followed, since part of the label from [1-14C]glucose is lost and part labels C-1 of ribose .44) while part of the label from [6-14C]glucose is lost and part labels C-5 of ribose.44)
Retention of C-6 may be via the hexose monophosphate pathway47) and retention of C-1 of glucose via the glucuronate pathway48) (Fig. 11) . The degradation scheme for deoxystreptamine in Fig. 8 (Table 2 ) demonstrated independently, without degradation, that C-6 of glucose labels the neosamine subunits at C-6 and labels ribose at C-5, as had been determined earlier in the carbon-14 studies. In addition, it was possible by CMR spectroscopy to locate the label at a single carbon atom, C-2, of deoxystreptamine.
A postulated biosynthetic route from glucose to deoxystreptamine which would give this result is shown in Fig. 12 . The substituent X may be either a hydroxyl group or a hydrogen atom. This route, involving initial oxidation and amination at C-3 of the aminocyclitol ring (which arises from C-5 of glucose), followed by similar reactions at C-1 of the aminocyclitol ring (from C-1 of glucose), is favored by analogy to results with streptidine to be discussed below. However, an alternative route (also shown in Fig. 12 ), involving the reverse sequence-oxidation-amination at the ring's C-1 first, followed by oxidation-amination at its C-3-cannot be ruled out by evidence obtained thus far.
A number of potential intermediates bet- with only C-1 of neosamines being labeled.
Similarly, when [1-13C]glucosamine was administered, the labeling pattern was as expected (Table 2) ,49) with C-1 of the neosamines, ribose and deoxystreptamine being labeled.
The neosamines are labeled at a much higher level by glucosamine than by glucose, which argues that glucosamine is further along the biosynthetic pathway to the neosamines than The neomycin produced was degraded ( Fig. 13) and the results (Table 3) In addition to labeled glucose and glucosamine, the labeled subunits themselves (except neosamine B) have been administered to S. fradiae to determine whether they are biosynthetic intermediates.
[1 14C]Ribose labeled all the subunits (Table 1) , presumably via glucose, but it labeled the ribose subunit most heavily and it was directly incorporated, since the label remained at the C-1 position of ribose in neomycin.45> [1-14C]Deoxystreptamine (isolated from neomycin derived from a [1-14C]glucose feeding) was also incorporated (Table 1) into the deoxystreptamine moiety of neomycin") and only into that moiety.
On the other hand, [1-14C]-neosamine C was found to be not incorporated into neomycin,") probably because the intermediates between glucosamine and the neosamine moieties of neomycin are enzyme-bound.
A second procedure has also been employed, in addition to feeding labeled deoxystreptamine, to demonstrate direct incorporation of deoxystreptamine into neomycin. Mutant strains of S. fradiae have been developed"-18) which produce neomycin only in the presence of added deoxystreptamine, thus confirming that it appears underivatized as a biosynthetic intermediate (Fig. 14) . The same mutants have also been employed in studying larger subunits as potential intermediates between deoxystreptamine and neomycin ( Fig. 14) . Neamine and ribostamycin were tested for bioconversion to neomycin, but no neomycin production was ob- demonstrates that neamine appears underivatized on the biosynthetic pathway to neomycin.
However, failure to obtain bioconversion to neomycin (negative results) can be explained in a number of ways:
(1) The order of subunit assembly may be one in which a subunit other than neosamine C (ribose or neobiosamine B) is joined to deoxystreptamine first, i.e., neamine may not be formed as such en route to neomycin.
(2) Deoxystreptamine may be converted to a derivative before a second subunit (neosamine C) is attached. This would give a derivative of the pseudodisaccharide subunit (neamine) and if no enzyme existed to convert the added pseudodisaccharide (neamine) to that derivative, the pseudodisaccharide's bioconversion to neomycin could not occur.
(3) The pseudodisaccharide intermediate (e.g. neamine) may be required to be enzymebound and not be taken up from the medium.
(4) The disaccharide intermediate (neamine) may not pass through the cell wall. [This is difficult to accept, since neamine was toxic to the producing cells, as noted above .]
Although details of the pseudodisaccharide and pseudotrisaccharide stages are still uncertain, some information exists about the final stages of neomycin biosynthesis. 81-ea> Derivatives of neomycin assigned phosphoamide structures have been reported to enhance antibiotic yields when added to the production media. In addition, an alkaline phosphatase which can convert these compounds to neomycin has been observed in the producing organism, and the de novo synthesis of this enzyme has been directly correlated to neomycin biosynthesis.e4 Thus, cleavage of a neomycin phosphoamide or phosphate has been postulated to be the last step in the biosynthesis of neomycin. Unfortunately, the position of the phosphorylation has not been determined. 
RIBOSTAMYCIN
As a practical outgrowth of the neomycin biosynthetic study, the same mutants used to study neomycin biosynthesis have been employed to prepare antibiotics related to neomycin by the incorporation of related aminocyclitols. Of many compounds administered which were related to deoxystreptamine, only streptamine and epistreptamine ( Fig. 15 ) were observed to be incorporated in early studies."-", 66,16) We refer to this procedure for preparing antibiotics as mutasynthesis, the antibiotics as mutasynthetics, and the aminocyclitols introduced as mutasynthons.
Paromomycin.
Paromomycins ( Fig. 1 ) are the product of S. rimosus forma paromomycinus. No studies have been reported on the biosynthesis of paromomycin employing labeled precursors. However, S. fradiae, which produces neomycin as the major product, has been shown to produce trace quantities of paromomycins as well, and the biosyntheses of the two antibiotics are, thus, presumably parallel. A mutant strain of S. rimosus forma paromomycinus has been developed which requires exogenous deoxystreptamine for antibiotic production (Fig. 16) ;11,11) thus, deoxystreptamine appears underivatized on the biosynthetic pathway to paromomycin as well. On the other hand, feeding the plausible pseudodisaccharide intermediate paromamine to the mutant of S. rimosus forma paromomycinus proved unsuccessful in producing paromomycin.69) Thus, the biosynthesis of paromomycin clearly mimics the neomycin pattern, as expected. A number of deoxystreptamine analogs were also administered, with results similar to those with the S. fradiae mutants; in this case the only analog incorporated was streptamine (Fig. 15) .
Ribostamycin.
No studies with labeled precursors have been reported employing S. ribosidificus, which produces ribostamycin (Fig. 1) . However, the biosynthesis must parallel that of neomycin since ribostamycin is a part of the latter antibiotic. Mutant strains of S. ribosidificus have been developed") which, like the S. fradiae and S. rimosus mutants, lack the ability to biosynthesize deoxystreptamine. When exogenous deoxystreptamine was added to the culture medium, ribostamycin was produced (Fig. 17) . Unlike the S. fradiae and S. rimosus mutants this mutant also bioconverted neamine to ribostamycin (Fig. 17) , which suggests that ribose is the last i.e., deoxystreptamine serves as a substrate for biosynthesis, but neamine does not.
It is significant that in butirosin both amino groups are attached to the aminocyclitol before 
corporated73> (2.6 % versus 0.9 % for glucose), but, again, no degradations have been reported.
The source of the methyl groups has been the cause of some confusion. Although both [2-14C]glycine and DL-[3-"C]serine were well incorporated73' (3.5 % and 2.8 %, respectively), by far the best incorporation (11.3 %) was obtained by feeding L-[methyl-14C]methionine to the growing microorganism in successive equivolume aliquots over a period of 48 hours.73' The distribution of radioactivity among the components of the complex was determined by radioscanning paper chromatograms, which separated the major components, gentamicins C,a, C., and C1. The results (Table 4) indicated that gentamicin C, (which contains two C-methyl and two Nmethyl groups) was more heavily labeled than gentamicin C2 (which contains one N-methyl group and two C-methyl groups), which in turn was more heavily labeled than gentamicin C1a (which contains one C-methyl and one N-methyl group). These results suggest both C-and N-methylation by methionine, but the ratios of the level of labeling (which should be 4 : 3 : 2 instead of the 60 : 18 : 3 found) do not support this argument quantitatively. In a later study") using L-[methyl-"Clmethionine, the gentamicin C components were separated by column chromatography and hydrolyzed into their subunits, which were separated from polar contaminants by paper chromatography and analyzed for relative radioactivity by radioscanning. The results (Table 5) showed that deoxystreptamine and C1 purpurosamine were unlabeled; this was expected, since neither unit contains C-or N-methyl groups. The gentamicin C, results (equal labeling of garosamine and CI-purpurosamine) would be explained if methionine labels both C-and N-methyl groups or if only C-or only N-methyl labeling occurs, because both garosamine and CI-purpurosamine contain both C-and N-methyl groups.
The gentamicin C2 results argue for only C-methylation by methionine, as garosamine (which contains one N-methyl and one C-methyl group) and C2-purpurosamine (which contains a C- Sisomicin.
Sisomicin is an analog of gentamicin which is characterized by an unsaturated aminosugar ( Fig. 2) . No results have been reported with labeled compounds, but a mutant of Micromonospora inyoensis has been recently reported") which requires exogenous deoxystreptamine for production of sisomicin. A number of pseudodisaccharides and pseudotrisaccharides (Fig. 22) containing deoxystreptamine were also administered") to the mutant. Two pseudodisaccharides were reported to be bioconverted to sisomicin and, of these, paromamine was a better substrate than neamine, suggesting either that neamine is first deaminated to paromamine or that the enzymes are somewhat non-selective and a parallel pathway exists to sisomicin. Sisomicin was not produced by the mutant in the presence of two other potential pseudodisaccharide precursors, gentamine C10 (3', 4'-dideoxyneamine) and garamine. Four pseudotrisaccharides (gentamicins A, A2, X2 and antibiotic 66-40B, Fig.22 ) were reported to allow production of sisomicin by the D-mutant, although only in the case of gentamicin A feeding was sufficient antibiotic produced to allow its chemical characterization as sisomicin. With the other three precursors, the antibiotic obtained was judged by thin-layer chromatography and paper chromatography to be sisomicin. Based on these results, TESTA and TILLEY7) have suggested a biosynthetic scheme for sisomicin ( Fig. 23 ) in which the role of neamine is unspecified.
There are a number of problems with this proposed biosynthesis. First, the sisomicin reported to be produced by these pseudotrisaccharides should be identified by chemical rather than chromatographic techniques. Second, one would, a priori, expect bioconversions in the hexose portions of sisomicin to take place on a nucleotide-bound substrate, as in the formation of dihydrostreptose discussed below. Consequently, the conversions of the pseudodisaccharides and pseudotrisaccharides may involve degradation to deoxystreptamine and its incorporation into sisomicin. TESTA and TILLEY argue that, since two other pseudodisaccharides and six other pseudotrisaccharides containing deoxystreptamine did not allow the formation of sisomicin, it was unlikely that the compounds tested were first degraded to deoxystreptamine and reincorporated into sisomicin. However, a selective enzymatic degradation of the successfully incorporated pseudodisaccharides and pseudotrisaccharides is possible. Their argument would be strengthened if the disaccharides and trisaccharides could be shown, perhaps by double labeling, to be incorporated as a unit.
As with the other D-mutants described above, new antibiotics were obtained through bioconversion of deoxystreptamine-in this case, streptamine, epi-streptamine, and 2, 5-dideoxystreptamine.
Antibiotics Containing Actinamine
Spectinomycin.
Spectinomycin and dihydrospectinomycin (Fig. 4) are the only antibiotics containing actinamine. Glucose serves as the source of the carbon skeleton, as it does for the other aminocyclitol antibiotics. When D-[6-3H]glucose was administered") to S. flavopersicus, 3.5 % of the label was incorporated into spectinomycin. Degradation of the compound (Fig. 24) located the label at C-6' of actinospectose (Table 6) Of greater interest is the location of label within the aminocyclitol, found at C-6.
MITSCIER"' had postulated that the C-1 and/or C-3 positions of actinamine would be labeled by C-6 of glucose, but no degradations were carried out to locate the labeled positions in the actinamine moiety. The carbon-13 data place the label specifically at C-6 of actinamine, which is similar to the results of the streptomycin carbon-13 studies described below.
The biosynthesis of actinamine apparently proceeds by a pathway related to that postulated for deoxystreptamine in Fig. 12 , but for actinamine the second amination occurs on the a-carbon (with respect to the first aminated carbon) in the counterclockwise direction (Fig. 26, path a) , while for deoxystreptamine it occurs in the clockwise direction (Fig. 26, path b) . Of course, the alternative path of Fig. 12 could also explain the deoxystreptamine results, in which case the initial carbon aminated would differ.
Of potential intermediates between glucose and spectinomycin (Table 6) produced. This result demonstrates that actinamine is directly incorporated into spectinomycin without prior degradation and, thus, that methylation takes place on the aminocyclitol before attachment of the sugar moiety. The methyl groups appear to be added as a last step in the biosynthesis of actinamine since, when unlabeled epi-streptamine and methyl-labeled methionine were given to the mutant, three radioactive materials in addition to methionine were observed at the end of fermentation -actinamine, spectinomycin, and actinospectinoic acid, a rearranged product whose structure is found in Fig. 24 . A control without epi-streptamine showed only labeled methionine present. N-Methyl.epi-streptamine also served as a precursor, again demonstrating the role of methionine as methylating agent.
Similar results (three radioactive spots) were obtained using the all-equatorial isomer of the aminocyclitol (N,N'-dimethylstreptamine, Fig. 15 ), but there was no biological activity associated with the radioactive spots.
Antibiotics Containing Streptidine and Bluensidine
Streptomycin.
The streptidine-containing antibiotics constitute an important group of compounds which were among the first antibiotics discovered. The structures of the streptomycin group were given in Fig. 4 and that of streptomycin is repeated in Fig. 28 with the subunits identified. The biosynthesis of streptomycin has been the subject of a number of recent reviews.55,81,82) Most of the information on streptomycin biosynthesis was derived from initial studies on the incorporation of radioactive precursors and from later enzymatic studies. At present no information is available on the order of formation of the glycosidic linkages which join the three moieties.
Early invest igations83) using n-[14C]glucose demonstrated that, as in all the other aminocyclitol antibiotics, glucose is the precursor to the skeletal carbon atoms of the streptomycin molecule. HUNTER and HOCKENHULL84) fed uniformly labeled n-glucose to S. griseus, achieving 5 % incorporation into the isolated streptomycin. Subsequent hydrolysis showed that all three subunits were approximately equally labeled (Table 8) .
Specifically labeled glucose has been used to study the biosynthesis of all of the subunits of streptomycin (Fig. 29 ) and results will now be discussed for the individual subunits. A number of hypothetical biosynthetic routes are possible for the formation of N-methyl-L-glucosamine from n-glucose, in which the principal point of interest is the inversion of stereochemistry. One possibility would involve de novo reassembly of the aminosugar from pieces derived from catabolism of n-glucose. Another possibility would involve intermediate cyclization to an inositol, in a process similar to that which gives rise to actinamine (preceding section) and to streptidine (see below), followed by cleavage at a bond different from that All mechanisms but the last were eliminated in the early work of SILVERMAN and RIEDER, 86) who fed specifically labeled D-glucose to S. griseus. The isolated streptomycin was degraded and the labeled positions located (Fig. 31, Table 9 ). Their scheme determined label at C-1 and C-6 and distinguished C-2 and C-3 from C-4 and C-5. Later, BRUTON, et al.,8i) used essentially the same scheme and employed other specifically labeled precursors. The results of these two groups (Table 9) suggest that D-glucose is incorporated as a unit into N-methyl-L-glucosamine, with carbons of the hexose becoming corresponding carbons of the hexosamine, although some catabolism is suggested by the enrichment of C-6 from C-1, as was also reported by AKAMATSU and ARAI.88> This has been explained") as resulting from the transaldolase-transketolase pathway, by which label at C-1 of glucose will label significantly C-1 and C-6 of N-methyl-Lglucosamine, whereas label from C-6 of glucose will significantly label only C-6 of N-methyl-L-glucosamine. The positions labeled rule out intermediate cyclitol formation; this would lead to specific incorporation, but different carbon atoms would be labeled (see Fig. 30 ).
Glucose labeled specifically at a number of positions has also been used to determine the labeling pattern in streptose.89-91.93> Streptomycin isolated from cultures of S. griseus was hydrolyzed to streptidine and streptobiosamine and the latter was further degraded to locate the position of label in streptose (Fig. 32) . The results (Table 10) show specific labeling of the streptose moiety: C-1 of glucose labels streptose at C-1, glucose C-3 labels streptose at C-3' (the formyl group), and glucose C-6 labels streptose at C-5. The results with specifically labeled glucose confirmed earlier studies, which argued that C-formylation is not a biosynthetic reaction in the formation of streptose. Possible formyl precursors, including L-[methyl-14C]-methionine and sodium [14C]-formate, were administered without incorporation into the formyl group,",") while L-[3-14C]serine was significantly but not specifically incorporated."
The labeling pattern in streptidine from feeding 14C-labeled glucose to S. griseus was re- (Table 9 ). Further, [1SN]glucosamine was found to label the streptobiosamine portion (and thus N-methyl-L-glucosamine) of streptomycin.103' However, better incorporation of glucosamine was found in the streptidine moiety, which has since been shown to arise directly from glucose.
Thus, the distribution of label in N-methyl-L-glucosamine suggests its formation from multiple stereochemical inversions of D-glucose via D-glucosamine.
The specific labeling pattern in streptose suggests a mechanism involving intramolecular carbon-carbon rearrangements of the glucose molecule. HORNER81) suggested two possible mechanisms for the formation of streptose based on the labeling patterns from glucose. The first involved formation of dTDP-rhamnose from glucose, followed by rearrangement at C-3 and C-4 to form streptose. This possibility was based on reports 114) that dTDP-rhamnose was isolated from cultures of S. griseus. Additionally, cell-free extracts of S. griseus can synthesize have shown that a third possibility is, however, the case (Fig. 34) . A cell-free extract of S. In addition, these researchers studied the enzymatic activity of X-amidinotransferase and dTDP-dihydrostreptose synthase in relation to streptomycin formation. The enzymes were seen to parallel one another and preceded streptomycin production. dTDP-Rhamnose production does not, however, seem to be directly involved with streptomycin biosynthesis. The amount of dTDP-L-rhamnose formed from dTDP-4-oxo-4,6-dideoxy-D-glucose is small early in the fermentation (20 % at 47 hours) but increases toward the end (35 0 at 186 hours), when dihydrostreptose is no longer formed."') dTDP-Dihydrostreptose could be involved with streptomycin biosynthesis in a number of ways. It may be that this compound is the primary rearrangement product of glucose and can subsequently be oxidized to dTDP-streptose. Alternatively, it may be incorporated into dihydrostreptomycin, which may be a precursor of streptomycin.
The enzyme extracts used in these did not produce dihydrostreptomycin in detectable amounts. Further work is needed to clarify the role of dTDP-dihydrostreptose in streptomycin biosynthesis.
An intermediate that has been studied for its conversion to streptidine is myo-inositol. Isotope dilution data"') suggest that myo-inositol plays a role in the biosynthesis of streptidine from glucose.
Labeled myo-inositol has also been shown to be well incorporated into streptidine; evidence has been presented above which rules out its initial conversion to glucose followed by incorporation. When myo-[2-14C]inositol was fed, incorporations were tenfold the Dglucose value and radioactivity was present exclusively in the streptidine portion."" Scylloinositol also serves as a precursor to streptidine,87 but it appears that this compound is first converted to myo-inositol, probably via myo-inosose-2, as has been demonstrated in rats"') and plants."') BRUTON, et a1.,87) observed the same level of incorporation in parallel experiments using scyllo-and myo-inositol, with essentially all of the label incorporated into the streptidine subunit. Analysis of the mycelial hydrolyzate for both scyllo-and myo-inositols showed that in the case of the myo-inositol feeding, only myo-inositol was labeled in the mycelium. When labeled scyllo-inositol was fed, again the labeled compound was myo-inositol. When labeled glucose was fed, only myo-inositol was labeled in the mycelium. The data to date suggest that D-glucose is converted to myo-inositol,107' probably by a mechanism similar to that reported by CHEN and CHARALAMPOUS"Il) and KINDL, et al.11z) in yeasts.
Labeling of C-6 of streptidine by D-[6-13C]glucose is in agreement with the conversion of glucose to streptidine via myo-inosose and pathway a of Fig. 35 . That this pathway is followed in both streptidine and actinamine biosynthesis but not in deoxystreptamine biosynthesis The mutant approach has also been applied to streptomycin biosynthesis.
In an early study,") a blocked mutant was shown to require a low molecular weight substance (" A-factor") in order to produce streptomycin. TOVAROVA, et a1.,191) reported that this "A-factor" was involved in streptidine biosynthesis but did not characterize this substance. More recently, NAGAOKA and DEMAIN6B) have isolated a mutant requiring streptidine for production of streptomycin ( Fig. 37 ) thus demonstrating that streptidine is incorporated intact into streptomycin .
This mutant did not produce streptomycin when streptamine (Fig . 15) The only disagreement with dephosphorylation as the last step in streptomycin biosynthesis comes from HEDING and BAIPAI,132) who suggested that methylation occurs last in streptomycin biosynthesis. They fed [methyl-14C]methionine, along with N-demethyldihydrostreptomycin and with a mixture of N-demethylstreptomycin and N-demethyldihydrostreptomycin in separate experiments, to active cultures of S. griseus. In the first case, dihydrostreptomycin was the only labeled product formed. In the second, streptomycin was the product labeled more heavily.
The strain of S. griseus used produced only streptomycin under control conditions. The authors concluded that both N-demethylstreptomycin and N-demethyldihydrostreptomycin are methylated by S. griseus, suggesting that the last step in biosynthesis is N-methylation. However, it must be pointed out that the level of added precursors was quite high (10 mg/ml) compared to the expected production in the control (2 mg/ml) and that the precursors were incubated for 28 hours, during which time both catabolism and anabolism might occur.
A cell-free system employing N-demethylstreptomycin and L-methionine would be of help in testing this hypothesis. On balance, it appears likely that dephosphorylation occurs as the final step in normal streptomycin biosynthesis.
Antibiotics Containing Monoaminocyclitols
Validamycin.
A recent paper"') has shown that D-[U-14C]glucose labels equally the three subunits of validamycin A (Fig. 38) , demonstrating that glucose serves as the carbon source for validamycin A. In addition, the pseudodisaccharide [14C]-validoxylamine A, was shown to be incorpo- the aminocyclitol antibiotics studied thus far, the enzymatic systems which convert glucose to some very similar compounds appear to vary considerably. It might be thought that streptidine (in streptomycin), actinamine (in spectinomycin) and deoxystreptamine (in neomycin) would be biosynthesized in a similar manner from glucose. It now appears that the addition of the second nitrogen to the monoaminocyclitol intermediate in neomycin biosynthesis49) takes place in a direction opposite that found in the streptomycin55.96) and spectinomycin48) systems (Figs. 26 and 36) , although an alternative pathway to deoxvstreptamine is possible (Fig. 12) . Additionally, inyo-inositol is well incorporated into the streptidine moiety of streptomycin108) and the actinamine moiety of spectinomycin,") whereas it is not incorporated into neomycin. 48) Other variations are evident, even with more closely related antibiotics. Neamine can be bioconverted to ribostamycin and sisomicin by deoxystreptamine-requiring mutants of S. ribosidifzcus87) and M. inyoensis,79) respectively, but similar mutants of S. fradiae,59) S. kanamyceticus,59.6T) B. circulans,08) and S. rimosus forma paromomycinus59) do not accept neamine (or paromamine) as a derivative of deoxystreptamine. The enzymes which convert glucosamine to glucose in S. fradiae (neomycin)") do not seem to be present in S. kanamyceticus (kanamycin), since glucosamine is well incorporated into all four neomycin subunits but this precursor labels kanamycin A in only the 6-amino-6-deoxy-n-glucose moiety.") Obviously, no comparison of biosynthetic pathways is valid between dissimilar moieties, but glucosamine (paromomycin) and N-methyl-L-glucosamine (streptomycin) are enantiomers, except for the methyl group. The formation of glucosamine from glucose is a straightforward bioconversion, 50) whereas the formation of N-methyl-L-glucosamine requires considerable enzymatic alteration. 88,87,89)
Conclusion
A great deal about the biosynthesis of this important class of antibiotics remains unknown. Little is certain about the order in which the subunits are joined, although it can be inferred from certain mutant studies",") that, at least in ribostamycin (and sisoticin) the order is neosamine C (or 2, 6-diamino-2, 3, 4, 6 tetradeoxy-D-glycero-hex-4-enose, dehydropurpurosamine) adding to deoxystreptamine, followed by addition of a third unit. The enzymatic steps of bioconversion of glucose to the subunits of the aminocyclitol antibiotics are well understood only for the streptidine moiety of streptomycin.63) The intermediate compounds for the other subunits are only partially characterized.
Much has been accomplished since the discovery of these important compounds in the late 1940's. Clearly much additional research effort remains to be expended before the biosynthesis of the aminocyclitol antibiotics is completely understood. The 
